Davidson J R, Giller E L, Zisook S, Helms M J
Duke University Medical Center, Durham, NC 27710.
Eur Arch Psychiatry Clin Neurosci. 1991;241(3):181-6. doi: 10.1007/BF02219719.
Multiple regression analysis was conducted on potential response predictors in a double-blind study of monoamine oxidase inhibitors (MAOI) and placebo treatment in 130 depressed outpatients. Positive main effects were found for sex (female), lack of prior hospitalization, presence of precipitating events. A negative main effect was found for concurrent physical illness. Treatment x predictor effects were found for distinct quality and non-reactivity. Non-reactivity was associated with positive outcome in the active drug group, but with negative outcome in the placebo group [corrected]. Distinct quality demonstrated a more complex effect, its presence being associated with decreased improvement in the treatment group and greater improvement in the control group. No atypical depressive symptoms predicted MAOI response, and we were unable to characterize a specifically responsive MAOI syndrome.
在一项针对130名门诊抑郁症患者的单胺氧化酶抑制剂(MAOI)与安慰剂治疗的双盲研究中,对潜在的反应预测因素进行了多元回归分析。发现性别(女性)、无既往住院史、存在诱发事件有正向主效应。发现并发躯体疾病有负向主效应。发现治疗×预测因素效应对独特质量和无反应性有影响。无反应性在活性药物组与阳性结果相关,但在安慰剂组与阴性结果相关[校正后]。独特质量显示出更复杂的效应,其存在与治疗组改善减少和对照组改善增加相关。没有非典型抑郁症状可预测MAOI反应,并且我们无法描述一种特异性反应性MAOI综合征。